Results

Total Results: 230 records

Showing results for "prostate cancer screening".
Users also searched for: psa

1. Prostate Cancer Screening | Effective Health Care (EHC) Program
   effectivehealthcare-admin.ahrq.gov/health-topics/prostate-cancer-screening
   Cancer Screening A B C D E F … There is no standard screening test for prostate cancer . … Your PSA level may be high if you have prostate cancer. … Prostate cancer screening has risks: Finding prostate cancer may not improve your health or help … cancer, the pros and cons of the screening tests, and whether you should get them.

2. Prostate-Cancer-Test Research-Protocol (pdf file)
   effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
   October 14, 2011 - ] (OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms” … of the prostate; levels may be elevated in association with other pathologies affecting the prostate … (prostate cancer antigen 3 [TIAB]) OR (prostatic cancer antigen 3 [TIAB]) OR DD3 antigen, human [ … test-specific set= 208 in PubMed Additionally - "Prostatic Neoplasms"[Mesh] OR "prostatic neoplasms … " OR "prostate neoplasms" OR "prostatic cancer" OR "prostate cancer" AND (nomogram OR (neural AND

3. Prostate-Cancer-Test Executive (pdf file)
   effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
   April 01, 2013 - Cancer Executive Summary Background Cancer of the prostate is the second most common cancer and … prostate cancer screening using tPSA was to reduce the prevalence of advanced prostate cancer and … Screening, risk assessment, and the approach to therapy in patients with prostate cancer. … Randomized Study of Screening for Prostate Cancer. … Screening for prostate cancer: a review of the evidence for the U.S.

4. Prostate-Cancer-Therapies-Update Executive (pdf file)
   effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
   December 01, 2014 - of the Prostate Risk Assessment (CAPRA). … Prostate-cancer screening--what the U.S. Preventive Services Task Force left out. … Why is prostate cancer screening so common when the evidence is so uncertain? … The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation … Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective

5. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
   effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-test/research-protocol
   December 01, 2019 - Despite the publication of thousands of articles on PSA and prostate cancer screening, the value of early … OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms”) AND … Prostate cancer screening practices in the general population at risk (men over the age of 50) may not … of the prostate; levels may be elevated in association with other pathologies affecting the prostate … - "Prostatic Neoplasms"[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR "prostatic cancer

6. Prostate-Cancer-Therapies-Update Research-Protocol (pdf file)
   effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
   April 01, 2013 - on the effect of PSA screening on prostate cancer mortality. … cancer EMBASE (EMTREE) Neoplasms/ Prostate/ Prostatic Neoplasms/ Cancer* Carcinoma* Neoplasm … cancer Prostatic Neoplasms/ 2 Prostate cancer (prostat$.ti,ab. or Prostate/) AND (cancer.ti,ab. or … cancer “prostatic neoplasms/surgery”[mesh] or “prostatic neoplasms/therapy”[mesh] OR “prostatic neoplasms … /radiotherapy”[mesh] 2 Prostate cancer “prostatic neoplasms”[mesh] OR (prostat*[tiab] AND (neoplasm*

7. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs | Effective Health Care (EHC) Program
   effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-antigen-3-gene/research
   December 01, 2019 - PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research … Structured Abstract Background Cancer of the prostate is the second most common cancer and the second … The prostate cancer antigen-3 gene (PCA3) has recently been found to be overexpressed in prostate cancers … Project Timeline PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs … https://effectivehealthcare.ahrq.gov/products/prostate-cancer-antigen-3-gene/research  

8. Prostate-Cancer-Risk-Assessment-Genes Executive (pdf file)
   effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
   July 01, 2012 - Prostate cancer: Current evidence weighs against population screening. … Screening for prostate cancer: An updated Cochrane systematic review. … Screening for prostate cancer: The controversy that refuses to die. … Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related … Screening for prostate cancer: A review of the evidence for the U.S.

9. Prostate Cancer | Effective Health Care (EHC) Program
   effectivehealthcare-admin.ahrq.gov/health-topics/prostate-cancer
   September 17, 2020 - Prostate cancer is common among older men. It is rare in men younger than 40. … Symptoms of prostate cancer may include Problems passing urine, such as pain, difficulty starting … These tests are also used in prostate cancer screening , which looks for cancer before you have symptoms … Men with prostate cancer have many treatment options. … Cancer Consumer Summary Archived January 21, 2016 Treating Localized Prostate Cancer

10. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer/research
    December 01, 2019 - Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer … cancer. … Project Timeline Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer … Adenocarcinoma Research Protocol Jul 22, 2024 Blood-based Tests for Multiple Cancer Screening … https://effectivehealthcare.ahrq.gov/products/prostate-cancer/research  

11. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/protocol
    March 01, 2020 - with prostate cancer have cancer confined to the prostate gland or clinically localized prostate cancer … Baseline PSA Gleason score Tumor index scores (e.g., Cancer of the Prostate Risk Assessment Score … EAU-ESTRO-SIOG Guidelines on Prostate Cancer. … Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. … of the Prostate Risk Assessment Score CLPC= clinically localized prostate cancer EAU= European Association

12. An Evidence Review of Active Surveillance in Men with Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-surveillance/research
    December 01, 2019 - An Evidence Review of Active Surveillance in Men with Localized Prostate Cancer … to an increase in prostate cancer incidence from the mid-1980s to the mid-1990s. … The prostate cancer-specific mortality rate decreased for all age groups from the early-1990s to 1999 … Currently, patients are diagnosed with earlier stage and lower risk prostate cancers compared to the … Conclusions More men are being diagnosed with early stage prostate cancer.

13. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/report
    January 01, 2021 - Therapies for Clinically Localized Prostate Cancer Systematic Review … Main Points In men with clinically localized prostate cancer (CLPC) detected clinically rather than … Therapies for clinically localized prostate cancer: a comparative effectiveness review . … Therapies for Clinically Localized Prostate Cancer. Comparative Effectiveness Review No. 230. … https://effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/report  

14. Multigene Panels in Prostate Cancer Risk Assessment | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-risk-assessment-genes/research
    December 01, 2019 - Multigene Panels in Prostate Cancer Risk Assessment Systematic … and full text screening. … All had poor discriminative ability for predicting risk of prostate cancer and/or distinguishing between … Project Timeline Multigene Panels in Prostate Cancer Risk Assessment Nov 22, 2011 … https://effectivehealthcare.ahrq.gov/products/prostate-cancer-risk-assessment-genes/research

15. Effective Health Care (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
    January 01, 2010 - cancers? … Do changes in screening and management for prostate cancer resulting from use of PCA3 assays lead to … What is the cost-effectiveness of using PCA3 assays to guide screening and management for prostate cancer … Potential for clinically significant prostate cancers to be missed in individuals presumed to be at … While there are currently several guidelines addressing total PSA testing and prostate cancer screening

16. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
    December 01, 2019 - on the effect of PSA screening on prostate cancer mortality. … Screening for prostate cancer: a review of the ERSPC and PLCO trials. … cancer Prostatic Neoplasms/ 2 Prostate cancer (prostat$.ti,ab. or Prostate/) AND (cancer.ti … cancer “prostatic neoplasms/surgery”[mesh] or “prostatic neoplasms/therapy”[mesh] OR “prostatic neoplasms … /radiotherapy”[mesh] 2 Prostate cancer “prostatic neoplasms”[mesh] OR (prostat*[tiab] AND (

17. Appendixes: Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendices.pdf
    May 22, 2024 - neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … neoplasms":ti OR "prostatic neoplasms":ti OR sarcomas:ti OR "stomach neoplasms":ti OR (tubo ovarian

18. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-test/research
    December 01, 2019 - PCA3 Testing for the Diagnosis and Management of Prostate Cancer Systematic … vs. aggressive therapy) in patients with prostate cancer positive biopsies. … of prostate cancer. … Project Timeline PCA3 Testing for the Diagnosis and Management of Prostate Cancer May 4, 2011 … https://effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research  

19. Therapies for Clinically Localized Prostate Cancer (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
    January 01, 2016 - Therapies for Clinically Localized Prostate Cancer Therapies for Clinically Localized Prostate Cancer … The Scandinavian Prostate Cancer Group-4 (SPCG-4) study (N = 695) and the Prostate Cancer Intervention … Prostate cancer–specific mortality: The SPCG-4 study found that RP reduced prostate cancer–specific … Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. … Prostate-specific antigen screening after 2012 US Preventive Services Task Force recommendations.

20. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/clinician
    December 01, 2019 - The Scandinavian Prostate Cancer Group-4 (SPCG-4) study (N = 695) and the Prostate Cancer Intervention … and reported data on prostate cancer–specific and all-cause mortality. … Prostate cancer–specific mortality : The SPCG-4 study found that RP reduced prostate cancer–specific … Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. … Prostate-specific antigen screening after 2012 US Preventive Services Task Force recommendations.